Prostaglandin E2 potentiates platelet aggregation by priming protein kinase C

Prostaglandin E2 potentiates platelet aggregation by priming protein kinase C

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	R Vezza, Rita Roberti, GG Nenci, Paolo Gresele
Format:	Artigo
Sprache:	Englisch
Veröffentlicht:	1993
Online-Zugang:	https://doi.org/10.1182/blood.v82.9.2704.2704 https://ashpublications.org/blood/article-pdf/82/9/2704/612085/2704.pdf
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Evidence for a storage pool defect in platelets from cirrhotic patients with defective aggregation
von: Giacomo Laffi, et al.
Veröffentlicht: (1992)

Intraplatelet signaling mechanisms of the priming effect of matrix metalloproteinase-2 on platelet aggregation
von: Emanuela Falcinelli, et al.
Veröffentlicht: (2005)

Activated human protein C prevents thrombin-induced thromboembolism in mice. Evidence that activated protein c reduces intravascular fibrin accumulation through the inhibition of additional thrombin generation.
von: Paolo Gresele, et al.
Veröffentlicht: (1998)

Potentiation of aggregation and inhibition of adenylate cyclase in human platelets by prostaglandin E analogues.
von: Matthews, J. S., et al.
Veröffentlicht: (1993)

Ca2+ mobilization primes protein kinase C in human platelets. Ca2+ and phorbol esters stimulate platelet aggregation and secretion synergistically through protein kinase C.
von: Siess, W, et al.
Veröffentlicht: (1988)

The mechanism of adenosine diphosphate induced platelet aggregation: binding to platelet receptors and inhibition of binding and aggregation by prostaglandin E(1)
von: Boullin, D. J., et al.
Veröffentlicht: (1972)

Formation of Prostaglandins during the Aggregation of Human Blood Platelets
von: Smith, J. B., et al.
Veröffentlicht: (1973)

Formation of Prostaglandins during the Aggregation of Human Blood Platelets
von: J. Bryan Smith, et al.
Veröffentlicht: (1973)

Prostaglandin E1 and forskolin antagonize C-kinase activation in the human platelet.
von: de Chaffoy de Courcelles, D, et al.
Veröffentlicht: (1987)

The mechanism of adenosine diphosphate induced platelet aggregation: binding to platelet receptors and inhibition of binding and aggregation by prostaglandin E<sub>1</sub>
von: D J Boullin, et al.
Veröffentlicht: (1972)

Effects of synthetic prostaglandin analogues on platelet aggregation and secretion [proceedings].
von: Corey, E J, et al.
Veröffentlicht: (1977)

Isolation and Structure of Two Prostaglandin Endoperoxides That Cause Platelet Aggregation
von: Hamberg, Mats, et al.
Veröffentlicht: (1974)

Isolation and Structure of Two Prostaglandin Endoperoxides That Cause Platelet Aggregation
von: Mats Hámberg, et al.
Veröffentlicht: (1974)

Platelet aggregation and exposure of fibrinogen receptors by prostaglandin endoperoxide analogues
von: TA Morinelli, et al.
Veröffentlicht: (1983)

Altered platelet function associated with the bronchial hyperresponsiveness accompanying nocturnal asthma
von: Paolo Gresele, et al.
Veröffentlicht: (1993)

Prostaglandin E(2 )acts via the EP(4 )receptor to inhibit platelet aggregation
von: Philipose, Sonia, et al.
Veröffentlicht: (2009)

Diabetes Mellitus, Hypercholesterolemia, and Hypertension but Not Vascular Disease Per Se Are Associated With Persistent Platelet Activation In Vivo
von: Giovanni Davı̀, et al.
Veröffentlicht: (1997)

Activated human protein C prevents thrombin-induced thromboembolism in mice. Evidence that activated protein c reduces intravascular fibrin accumulation through the inhibition of additional thrombin generation.
von: Gresele, P, et al.
Veröffentlicht: (1998)

Effect of ethanol on vascular prostacyclin (prostaglandin I2) synthesis, platelet aggregation, and platelet thromboxane release.
von: Mikhailidis, D P, et al.
Veröffentlicht: (1983)

Effect of ethanol on vascular prostacyclin (prostaglandin I2) synthesis, platelet aggregation, and platelet thromboxane release.
von: Dimitri P. Mikhailidis, et al.
Veröffentlicht: (1983)

Inhibition of prostaglandin E1-responsive platelet adenylate cyclase by heparin: a study of the mechanism of inhibition and its relevance to platelet aggregation
von: Amirrasooli, H., et al.
Veröffentlicht: (1981)

The Prostaglandin E <sub>2</sub> Receptor EP4 Is Expressed by Human Platelets and Potently Inhibits Platelet Aggregation and Thrombus Formation
von: Sonia Philipose, et al.
Veröffentlicht: (2010)

Thrombopoietin primes human platelet aggregation induced by shear stress and by multiple agonists
von: A. Oda, et al.
Veröffentlicht: (1996)

Inhibition of platelet aggregation by prostaglandin E1 (PGE1) in diabetic patients during therapy with clopidogrel and aspirin
von: KREUTZ, ROLF P., et al.
Veröffentlicht: (2012)

Anti-platelet therapy: phosphodiesterase inhibitors
von: Gresele, Paolo, et al.
Veröffentlicht: (2011)

Anti‐platelet therapy: phosphodiesterase inhibitors
von: Paolo Gresele, et al.
Veröffentlicht: (2011)

LPS stimulates platelet secretion and potentiates platelet aggregation via TLR4/MyD88 and the cGMP-dependent protein kinase pathway
von: Zhang, Guoying, et al.
Veröffentlicht: (2009)

Lipopolysaccharide Stimulates Platelet Secretion and Potentiates Platelet Aggregation via TLR4/MyD88 and the cGMP-Dependent Protein Kinase Pathway
von: Guoying Zhang, et al.
Veröffentlicht: (2009)

Prostaglandin endoperoxides, thromboxane A2 and adenosine diphosphate in collagen-induced aggregation of rabbit platelets
von: Lewis, G. P., et al.
Veröffentlicht: (1982)

Single-blind study of epoprostenol and 6-keto-prostaglandin E1 in man: effects of platelet aggregation and plasma renin.
von: Miyamori, I, et al.
Veröffentlicht: (1985)

Platelets and Airway Diseases
von: Momi, Stefania, et al.
Veröffentlicht: (2017)

The effect of a prostaglandin DP-receptor partial agonist (192C86) on platelet aggregation and the cardiovascular system in healthy volunteers.
von: Gray, S J, et al.
Veröffentlicht: (1992)

Learning the Ropes of Platelet Count Regulation: Inherited Thrombocytopenias
von: Bury, Loredana, et al.
Veröffentlicht: (2021)

Proceedings: Effects of prostaglandins E1, E2 and D2 on platelet aggregation: variation with animal species and ionized calcium concentration.
von: Gordon, J L, et al.
Veröffentlicht: (1975)

Receptor- and phorbol-ester-mediated redistribution of protein kinase C in human platelets. Evidence that aggregation promotes degradation of protein kinase C.
von: Wheeler-Jones, C P, et al.
Veröffentlicht: (1989)

Antiplatelet Therapy in Low-Platelet-Count Patients After Percutaneous Coronary Intervention for Acute Coronary Syndromes
von: Francesco Paciullo, et al.
Veröffentlicht: (2025)

Effect of prostaglandin E1 alone and in combination with theophylline or aspirin on collagen-induced platelet aggregation and on platelet nucleotides including adenosine 3′:5′-cyclic monophosphate
von: Ball, G., et al.
Veröffentlicht: (1970)

Effect of prostaglandin E1 alone and in combination with theophylline or aspirin on collagen-induced platelet aggregation and on platelet nucleotides including adenosine 3′:5′-cyclic monophosphate
von: Ge. Ball, et al.
Veröffentlicht: (1970)

Creatine kinase inhibits ADP-induced platelet aggregation
von: Horjus, D. L., et al.
Veröffentlicht: (2014)

The effect of pulmonary metabolites of prostaglandins E1, E2 and F2alpha on ADP-induced aggregation of human and rabbit platelets [proceedings].
von: Westwick, J
Veröffentlicht: (1976)